New patent expiration for Valinor drug MOVANTIK
Annual Drug Patent Expirations for MOVANTIK Movantik is a drug marketed by Valinor and is included in one NDA. It […]
Source
Annual Drug Patent Expirations for MOVANTIK Movantik is a drug marketed by Valinor and is included in one NDA. It […]
Source
MOVANTIK (naloxegol oxalate) Valinor Patent: 7,056,500 Expiration: Jun 29, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit www.DrugPat…
Drug Patent Expirations for the Week of June 23, 2024 Read Post »
MOVANTIK (naloxegol oxalate) Valinor Patent: 7,056,500 Expiration: Jun 29, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit www.DrugPat…
Drug Patent Expirations for the Week of June 23, 2024 Read Post »
Annual Drug Patent Expirations for XIFAXAN Xifaxan is a drug marketed by Salix Pharms and is included in one NDA. It is available from three suppliers. There are twenty-nine patents protecting this drug and two Paragraph IV challenges. XIFAXAN drug pri…
New patent expiration for Salix Pharms drug XIFAXAN Read Post »
Annual Drug Patent Expirations for TPOXX Tpoxx is a drug marketed by Siga Technologies and is included in two NDAs. It is available from one supplier. There are ten patents protecting this drug. This drug has ninety-one patent family members in twenty-…
New patent expiration for Siga Technologies drug TPOXX Read Post »
Annual Drug Patent Expirations for NUVIGIL Nuvigil is a drug marketed by Cephalon and is included in one NDA. It is available from seven suppliers. There are two patents protecting this drug and two Paragraph IV challenges. NUVIGIL drug price trends. D…
Annual Drug Patent Expirations for ABILIFY+MYCITE+KIT Abilify Mycite Kit is a drug marketed by Otsuka and is included in one NDA. It is available from one supplier. There are twenty-eight…
Source
New patent expiration for Otsuka drug ABILIFY MYCITE KIT Read Post »
ABRAXANE (paclitaxel) Bristol-myers Patent: 8,314,156 Expiration: Jun 9, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
Source
Drug Patent Expirations for the Week of June 9, 2024 Read Post »
Annual Drug Patent Expirations for ABRAXANE Abraxane is a drug marketed by Bristol-myers and is included in one NDA. It is available from three suppliers. There are eleven patents protecting…
Source
New patent expiration for Bristol-myers drug ABRAXANE Read Post »
Annual Drug Patent Expirations for ILEVRO Ilevro is a drug marketed by Harrow Eye and is included in one NDA. It is available from two suppliers. There are three patents…
Source
New patent expiration for Harrow Eye drug ILEVRO Read Post »